IL84312A - Ifosfamide lyophilisate and its preparation - Google Patents

Ifosfamide lyophilisate and its preparation

Info

Publication number
IL84312A
IL84312A IL84312A IL8431287A IL84312A IL 84312 A IL84312 A IL 84312A IL 84312 A IL84312 A IL 84312A IL 8431287 A IL8431287 A IL 8431287A IL 84312 A IL84312 A IL 84312A
Authority
IL
Israel
Prior art keywords
ifosfamide
preparation
lyophilisate
ifosfamide lyophilisate
weight
Prior art date
Application number
IL84312A
Other languages
English (en)
Other versions
IL84312A0 (en
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of IL84312A0 publication Critical patent/IL84312A0/xx
Publication of IL84312A publication Critical patent/IL84312A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of El Displays (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Indole Compounds (AREA)
  • Amplifiers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL84312A 1986-10-31 1987-10-29 Ifosfamide lyophilisate and its preparation IL84312A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31

Publications (2)

Publication Number Publication Date
IL84312A0 IL84312A0 (en) 1988-03-31
IL84312A true IL84312A (en) 1991-11-21

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84312A IL84312A (en) 1986-10-31 1987-10-29 Ifosfamide lyophilisate and its preparation

Country Status (25)

Country Link
EP (1) EP0265812B1 (es)
JP (1) JPS63159319A (es)
KR (1) KR900003491B1 (es)
AT (1) ATE55250T1 (es)
AU (1) AU598602B2 (es)
CA (1) CA1314231C (es)
DD (1) DD262582A5 (es)
DE (1) DE3764235D1 (es)
DK (1) DK169308B1 (es)
EG (1) EG18333A (es)
ES (1) ES2017982B3 (es)
FI (1) FI87140C (es)
GE (1) GEP19971025B (es)
GR (1) GR3000708T3 (es)
HU (1) HU197987B (es)
IL (1) IL84312A (es)
IN (1) IN168119B (es)
LV (1) LV10051B (es)
MX (1) MX8958A (es)
NO (1) NO873860L (es)
PT (1) PT86032B (es)
RU (1) RU1836079C (es)
UA (1) UA11075A (es)
YU (1) YU197387A (es)
ZA (1) ZA878183B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334083B1 (de) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
CN1299277A (zh) * 1998-03-03 2001-06-13 盐野义制药株式会社 含有磷脂酶抑制剂[[3－(2－氨基－1,2－二氧乙基)－2－乙基－1(苯甲基)－1h－吲哚－4－基]氧基]乙酸钠的药用组合物
JP2006508917A (ja) * 2002-09-05 2006-03-16 ブハラット セルムズ アンド ヴァクシンズ リミテッド メスナを有する、オキサザホスホリンの液体安定性組成物
CA2507848A1 (en) * 2002-12-02 2004-06-17 Bharat Serums & Vaccines Ltd. Ifosfamide compositions for parenteral administration and a process for their preparation
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
PL2071917T3 (pl) * 2006-09-29 2013-04-30 Infa Sa System opakowaniowy dla kompozycji farmaceutycznych oraz zestaw do podawania dożylnego
CN105900385B (zh) * 2014-12-04 2019-08-27 华为技术有限公司 在数据通信网中的负载分配

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (de) * 1977-05-09 1978-11-16 Walton J Smith Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung
EP0083439B1 (de) * 1981-12-31 1989-07-26 ASTA Pharma AG 4-Sulfido-oxazaphosphorine und deren Verwendung bei der Krebsbekämpfung und zur Immunsuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
EP0265812A1 (de) 1988-05-04
GR3000708T3 (en) 1991-10-10
IL84312A0 (en) 1988-03-31
LV10051A (lv) 1994-05-10
MX8958A (es) 1993-12-01
IN168119B (es) 1991-02-09
AU598602B2 (en) 1990-06-28
JPH0543684B2 (es) 1993-07-02
EP0265812B1 (de) 1990-08-08
FI874727A (fi) 1988-05-01
DE3764235D1 (de) 1990-09-13
ES2017982B3 (es) 1991-03-16
HU197987B (en) 1989-07-28
RU1836079C (ru) 1993-08-23
FI874727A0 (fi) 1987-10-27
UA11075A (uk) 1996-12-25
ATE55250T1 (de) 1990-08-15
EG18333A (en) 1993-12-30
ZA878183B (en) 1988-05-02
HUT44932A (en) 1988-05-30
AU8052987A (en) 1988-05-05
KR900003491B1 (ko) 1990-05-21
FI87140C (fi) 1992-12-10
NO873860L (no) 1988-05-02
KR880004814A (ko) 1988-06-27
YU197387A (en) 1988-12-31
DK169308B1 (da) 1994-10-10
PT86032A (de) 1987-11-01
JPS63159319A (ja) 1988-07-02
LV10051B (en) 1995-06-20
DK569687A (da) 1988-05-01
PT86032B (pt) 1990-08-31
FI87140B (fi) 1992-08-31
DD262582A5 (de) 1988-12-07
DK569687D0 (da) 1987-10-30
NO873860D0 (no) 1987-09-15
CA1314231C (en) 1993-03-09
GEP19971025B (en) 1997-04-06

Similar Documents

Publication Publication Date Title
ZA894728B (en) A new pharmaceutical formulation as well as a process for its preparation
GR3007251T3 (es)
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
EP0196524A3 (en) Phenoxyalkylaminopyrimidine derivatives, their preparation and insecticidal and acaricidal compositions containing them
GR3002377T3 (en) Ifosfamide-mesna-lyophilized composition and process to prepare it
HUT44438A (en) Composition comprising l-dopa
IL84312A0 (en) Ifosfamide lyophilisate and its preparation
IL81602A0 (en) Substituted 1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acids,their preparation and pharmaceutical compositions containing them
IL83412A (en) 5',5'-disubstituted 2',5'-dideoxyuridines and 2',5'-dideoxycytidines,their preparation and pharmaceutical compositions containing them
ZA886107B (en) Antiviral preparation
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
IL82145A0 (en) Substituted thiacycloalkeno(3,2-b)pyridines,their preparation and pharmaceutical compositions containing them
IL84551A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
IL87134A0 (en) Preparation of 1,2,4-triazol-3-ones
KR900700484A (ko) 1,4:3,6-디안히드로 헥시톨 잘산염의 아미노프로판올 유도체,그의 제법 및 약제로서의 그의 용도
OA09419A (fr) Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo (3.2.0.) -hept-2-ene-2-carboxylique et leur préparation.
IL87173A (en) 4-heterocyclyl thio-phenyl-thiourea,isothiourea and/or carbodiimide derivatives,their preparation and insecticidal and acaricidal compositions containing them
IL83370A0 (en) Preparation of 3,4-diamino-5-benzylpyrimidines
IL89631A (en) Preparation of 2,6-dioxopiperidine derivatives
IL83606A0 (en) Derivatives of 2,2-dimethyl-cyclopropanecarboxylic acid,their preparation and their use as insecticides and acaricides
IE861999L (en) Preparation of 5,6-dialkoxyanthranilic acids

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired